Thanks for your feedback, this will help us improve our content for you!
Thank for your feedback, this will help us improve our content for you!
Tarek H Mouhieddine, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the pathology and prognosis of monoclonal gammopathy of undetermined significance (MGUS) at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter